Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5348206012 | Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5348207015 | Hydrocortisone acetate 15 mg/g and neomycin sulfate 5 mg/g ear and eye ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
468230010 | Neomycin+hydrocortisone 0.5%/1.5% eye/ear ointment | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
468230010 | Neomycin+hydrocortisone 0.5%/1.5% eye/ear ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
721036014 | Neomycin+hydrocortisone 0.5%/1.5% eye/ear ointment (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1192337018 | Neomycin+hydrocortisone 0.5%/1.5% eye/ear ointment (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
1192337018 | Neomycin+hydrocortisone 0.5%/1.5% eye/ear ointment (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3693703010 | Hydrocortisone acetate 15 mg/g and neomycin sulfate 5 mg/g ear or eye ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3693704016 | Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3693705015 | Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear or eye ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5348206012 | Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
5348207015 | Hydrocortisone acetate 15 mg/g and neomycin sulfate 5 mg/g ear and eye ointment | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Compound neomycin preparations | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Topical neomycin | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Topical neomycin | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Hydrocortisone | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Neomycin | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | anti-infectieux cutané | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Product containing hydrocortisone and neomycin (medicinal product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Corticosterone | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Adrenal hormone agent | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Bactericide | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Local anti-infective | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has manufactured dose form | Conventional release ear and eye ointment (dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has basis of strength substance (attribute) | Neomycin sulphate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has precise active ingredient | Neomycin sulphate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has basis of strength substance (attribute) | Hydrocortisone acetate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has concentration strength denominator unit (attribute) | g | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has concentration strength numerator value | cinq | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has concentration strength numerator value | 15 | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has precise active ingredient | Hydrocortisone acetate | false | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has concentration strength denominator unit (attribute) | g | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Product containing hydrocortisone in otic dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Product containing hydrocortisone in ocular dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Product containing neomycin in otic dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Product containing neomycin in ophthalmic dosage form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Neomycin-containing product in ocular dose form | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Product containing only hydrocortisone and neomycin (medicinal product) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Hydrocortisone and neomycin only product in ocular dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Is a | Hydrocortisone and neomycin only product in otic dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has precise active ingredient | Hydrocortisone acetate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has precise active ingredient | Neomycin sulphate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has basis of strength substance (attribute) | Neomycin sulphate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
Product containing precisely hydrocortisone acetate 15 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release ear and eye ointment (clinical drug) | Has basis of strength substance (attribute) | Hydrocortisone acetate | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets